Phenformin as prophylaxis and therapy in breast cancer xenografts

BACKGROUND: Observations that diabetics treated with biguanide drugs have a reduced risk of developing cancer have prompted an enthusiasm for these agents as anti-cancer therapies. We sought to determine the efficacy of the biguanide phenformin in the chemoprophylaxis and in the treatment of oestrog...

Descripción completa

Detalles Bibliográficos
Autores principales: Appleyard, M V C L, Murray, K E, Coates, P J, Wullschleger, S, Bray, S E, Kernohan, N M, Fleming, S, Alessi, D R, Thompson, A M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2012
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304424/
https://www.ncbi.nlm.nih.gov/pubmed/22361631
http://dx.doi.org/10.1038/bjc.2012.56

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3304424/
https://www.ncbi.nlm.nih.gov/pubmed/22361631
http://dx.doi.org/10.1038/bjc.2012.56

Ejemplares similares